Temporal Trends in the Treatment of Pediatric Type 1 Diabetes and Impact on Acute Outcomes

Journal of Pediatrics

Volumn 150, Issue 3, 2007, Pages 279-285

  Svoren, Britta M ^a,b   Volkening, Lisa K ^a   Butler, Deborah A ^a   Moreland, Elaine C ^c   Anderson, Barbara J ^d   Laffel, Lori M B ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHILDHOOD DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INCIDENCE; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GLUCOSE TOLERANCE TEST; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33847335920     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.12.009     Document Type: Article

References (45)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
2. Silverstein J., Klingensmith G., Copeland K., Plotnick L., Kaufman F., Laffel L., et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28 (2005) 186-212
3. Haller M.J., Stalvey M.S., and Silverstein J.H. Predictors of control of diabetes: monitoring may be the key. J Pediatr 144 (2004) 660-661
4. Nathan D.M., McKitrick C., Larkin M., Schaffran R., and Singer D.E. Glycemic control in diabetes mellitus: have changes in therapy made a difference?. Am J Med 100 (1996) 157-163
5. Levine B.S., Anderson B.J., Butler D.A., Brackett J., and Laffel L. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 139 (2001) 197-203
6. Moreland E.C., Tovar A., Zuehlke J.B., Butler D.A., Milaszewski K., and Laffel L.M. The impact of physiological, therapeutic and psychosocial variables on glycemic control in youth with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 17 (2004) 1533-1544
7. Amiel S.A., Sherwin R.S., Simonson D.C., Lauritano A.A., and Tamborlane W.V. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315 (1986) 215-219
8. Rydall A.C., Rodin G.M., Olmsted M.P., Devenyi R.G., and Daneman D. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 336 (1997) 1849-1854
9. Wysocki T., Taylor A., Hough B.S., Linscheid T.R., Yeates K.O., and Naglieri J.A. Deviation from developmentally appropriate self-care autonomy. Association with diabetes outcomes. Diabetes Care 19 (1996) 119-125
10. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125 (1994) 177-188
11. Bui H., Perlman K., and Daneman D. Self-monitoring of blood glucose in children and teens with diabetes. Pediatr Diabetes 6 (2005) 50-62
12. Tamborlane W.V., Bonfig W., and Boland E. Recent advances in treatment of youth with type 1 diabetes: better care through technology. Diabet Med 18 (2001) 864-870
13. Laffel L.M., Vangsness L., Connell A., Goebel-Fabbri A., Butler D., and Anderson B.J. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 142 (2003) 409-416
14. Grey M., Boland E.A., Davidson M., Li J., and Tamborlane W.V. Coping skills training for youth with diabetes mellitus has long- lasting effects on metabolic control and quality of life. J Pediatr 137 (2000) 107-113
15. The Diabetes Control and Complications Trial Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 11 (1988) 567-573
16. Wing R.R., Klein R., and Moss S.E. Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes. Diabetes Care 13 (1990) 1106-1109
17. The Diabetes Control and Complications Trial Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18 (1995) 1415-1427
18. Jones T.W., and Davis E.A. Hypoglycemia in children with type 1 diabetes: current issues and controversies. Pediatr Diabetes 4 (2003) 143-150
19. Chase H.P., Lockspeiser T., Peery B., Shepherd M., Mackenzie T., Anderson J., et al. The impact of the Diabetes Control and Complications Trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care 24 (2001) 430-434
20. Bulsara M.K., Holman C.D., Davis E.A., and Jones T.W. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 27 (2004) 2293-2298
21. The Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90 (1991) 450-459
22. Mortensen H.B., and Hougaard P. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes. Diabetes Care 20 (1997) 714-720
23. Danne T., Mortensen H.B., Hougaard P., Lynggaard H., Aanstoot H.J., Chiarelli F., et al. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 24 (2001) 1342-1347
24. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 suppl 1 (2006) S4-S42
25. Kaufman F.R., Halvorson M., and Carpenter S. Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic. Pediatrics 103 (1999) 948-951
26. Svoren B.M., Butler D., Levine B.S., Anderson B.J., and Laffel L.M.B. Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial. Pediatrics 112 (2003) 914-922
27. Laffel L., Brackett J., Ho J., and Anderson B.J. Changing the process of diabetes care improves metabolic outcomes and reduces hospitalizations. Qual Manag Health Care 6 (1998) 53-62
28. Daneman D., Wolfson D.H., Becker D.J., and Drash A.L. Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes. J Pediatr 99 (1981) 847-853
29. Jacobson A.M., Hauser S.T., Lavori P., Willett J.B., Cole C.F., Wolfsdorf J.I., et al. Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med 56 (1994) 401-409
30. Ingersoll G.M., Orr D.P., Herrold A.J., and Golden M.P. Cognitive maturity and self-management among adolescents with insulin-dependent diabetes mellitus. J Pediatr 108 (1986) 620-623
31. Palmer A.J., Roze S., Valentine W.J., Minshall M.E., Lammert M., Nicklasson L., et al. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy. Curr Med Res Opin 20 suppl 1 (2004) S67-S73
32. Rosilio M., Cotton J.B., Wieliczko M.C., Gendrault B., Carel J.C., Couvaras O., et al., The French Pediatric Diabetes Group. Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 21 (1998) 1146-1153
33. Hepburn D.A., Patrick A.W., Eadington D.W., Ewing D.J., and Frier B.M. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 7 (1990) 711-717
34. Pickup J., Mattock M., and Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324 (2002) 705-708
35. Pickup J., and Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25 (2002) 593-598
36. Brunelle B.L., Llewelyn J., Anderson Jr. J.H., Gale E.A., and Koivisto V.A. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21 (1998) 1726-1731
37. Heller S.R., Amiel S.A., Mansell P., and UK Lispro Study Group. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care 22 (1999) 1607-1611
38. Davey P., Grainger D., MacMillan J., Rajan N., Aristides M., and Gliksman M. Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis. Clin Ther 19 (1997) 656-674
39. Heinemann L. Hypoglycemia and insulin analogues: is there a reduction in the incidence?. J Diabetes Complications 13 (1999) 105-114
40. Hogan P., Dall T., and Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
41. Curtis J.R., To T., Muirhead S., Cummings E., and Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes Care 25 (2002) 1591-1596
42. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA 276 (1996) 1409-1415
43. Eastman R.C., Javitt J.C., Herman W.H., Dasbach E.J., Copley-Merriman C., Maier W., et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 20 (1997) 735-744
44. Stern Z., and Levy R. Analysis of direct cost of standard compared with intensive insulin treatment of insulin-dependent diabetes mellitus and cost of complications. Acta Diabetol 33 (1996) 48-52
45. Rewers A., Chase H.P., Mackenzie T., Walravens P., Roback M., Rewers M., et al. Predictors of acute complications in children with type 1 diabetes. JAMA 287 (2002) 2511-2518